MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$697,264K
Net Income
-$150,276K
Net Profit Margin
-21.55%
EPS
-$1.94
Unit: Thousand (K) dollars
Revenue Breakdown
Diabetes Product
Sleep Therapy Product
Home Respiratory Therapy Product
Others
Revenue Breakdown
Commercial Payors
Medicare
Medicaid
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Net revenue
697,264
681,917
2,632,048
2,381,527*
Cost of net revenue
375,067
357,315
2,106,035
2,049,320*
Gross profit
-
-
526,013
332,207*
Selling, general and administrative expenses
265,838
267,853
462,352
501,125*
Transaction breakage fee
-
80,000
-
-
Other operating expense (income), net
-
-
-2,637
18,169*
Acquisition-related charges and intangible amortization
29,229
13,918
29,674
24,920*
Exit and realignment charges, net
660
2,541
31,226
22,903*
Goodwill impairment charge
-
-
-
76,778*
Total operating costs and expenses
670,794
721,627
-
-
Loss (gain) on extinguishment of debt
-
-
-
-275*
Operating income
26,470
-39,710
124
-275,349*
Interest expense, net
29,029
26,009
33,959
35,125*
Transaction financing fees, net
-
18,288
-
-
Other expense, net
-1,076
-942
-1,239
-718*
(loss) income from continuing operations before income taxes
-3,635
-84,949
-35,074
-311,467*
Income tax provision (benefit)
1,972
-1,127
-10,092
-15,806*
(loss) income from continuing operations, net of tax
-5,607
-83,822
-
-
Loss from discontinued operations, net of tax
-144,669
-785,236
-
-
Net loss
-150,276
-869,058
-24,982
-295,661
Basic EPS
-1.94
-11.3
-0.32
-3.87
Diluted EPS
-1.94
-11.3
-0.32
-3.87
Basic Average Shares
77,288,000
76,935,000
77,272,000
76,406,000
Diluted Average Shares
77,288,000
76,935,000
77,272,000
76,406,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
-$150,276K
(-1076.79%↓ Y/Y)
Diabetes Product
$201,372K
Sleep Therapy Product
$185,799K
Home Respiratory
Therapy Product
$107,256K
Product And Service
Other
$72,586K
Ostomy
$53,274K
Wound Care
$48,001K
Urology
$28,976K
Loss from
discontinued operations, net...
-$144,669K
(loss) income from
continuing operations, net...
-$5,607K
Net revenue
$697,264K
(-74.38%↓ Y/Y)
(loss) income from
continuing operations...
-$3,635K
(73.64%↑ Y/Y)
Income tax provision
(benefit)
$1,972K
(293.71%↑ Y/Y)
Operating income
$26,470K
(9.36%↑ Y/Y)
Total operating costs
and expenses
$670,794K
Interest expense, net
$29,029K
(-20.59%↓ Y/Y)
Other expense, net
-$1,076K
(25.17%↑ Y/Y)
Cost of net revenue
$375,067K
(-82.65%↓ Y/Y)
Selling, general and
administrative expenses
$265,838K
(-43.41%↓ Y/Y)
Acquisition-related charges and
intangible amortization
$29,229K
(38.55%↑ Y/Y)
Exit and realignment
charges, net
$660K
(-97.71%↓ Y/Y)
Buy us a coffee
OWENS & MINOR INC VA (OMI)
OWENS & MINOR INC VA (OMI)